摘要
目的探讨急诊经皮冠状动脉介入对急性心肌梗死患者的应用效果及手术安全性。方法回顾性分析2015年3月—2018年2月在佳木斯市中心医院治疗的122例急性心肌梗死患者的临床资料,依据治疗方案的不同,分为对照组(溶栓治疗,61例)与观察组(急诊经皮冠状动脉介入治疗,61例),比较两组N-末端脑钠肽前体(Nterminal pro B type natriureticpeptide,NT-proBNP)含量、并发症发生情况。结果治疗后各时间段,观察组NT-proBNP含量均低于对照组,差异有统计学意义(P<0.05);观察组治疗安全性高于对照组,差异有统计学意义(P<0.05)。结论急性心肌梗死患者通过急诊经皮冠状动脉介入治疗,可有效调节NT-proBNP含量,且并发症发生率较低,具有一定安全性。
Objective To evaluate the efficacy and safety of emergency percutaneous coronary intervention(PCI)in patients with acute myocardial infarction(AMI). Methods The clinical data of 122 patients with acute myocardial infarction treated in the hospital from March,2015 to February,2018 were retrospectively analyzed. They were divided into observation group(emergency percutane ous coronary intervention,61 cases)and control group(thrombolytic therapy,61 cases). Comparison of the content of N-terminal brain natriuretic peptide precursor(N terminal pro B type natriuretic peptide,NT-proB NP)and the occurrence of complications be tween two groups was done. Results The content of NT-proBNP in the observation group was lower than that in the control group(P< 0.05),and the safety of treatment in the observation group was higher than that in the control group(P<0.05). Conclusion Emergen cy percutaneous coronary intervention in acute myocardial infarction patients can effectively regulate the content of NT-proBNP,the incidence of complications is relatively low,and it has a certain safety.
作者
张立敏
田园
ZHANG Li-min;TIAN Yuan(The Second Department of Cardiolgy. The Central Hospital of Jianusi City,Jiamusi,Heilongjiang,154002, China)
出处
《黑龙江医学》
2019年第9期1063-1064,共2页
Heilongjiang Medical Journal
关键词
急性心肌梗死
急诊经皮冠状动脉介入术
安全性
Acute myocardial infarction
Emergency percutaneous coronary intervention
Safety
